Abstract
A first feasibility study about the sirolimus release from stent coatings based on degradable poly(3-hydroxyalkanoate)s PHAs is reported. Natural poly(3-hydroxybutyrate-co-3-hydroxyvalerate) PHBHV, poly(3-hydroxyoctanoate) PHO, functional polyesters containing carboxylic groups PHO75COOH25, and diblock copolymer poly((3-hydroxybutyrate-co-3-hydroxyvalerate)-b-(lactic acid)) P(HBHV-b-LA) were sprayed onto metallic stents. Stress behavior and coating integrity studied by scanning electron microscopy on unexpanded and expanded stents were found to be superior for the PHBHV and P(HBHV-b-LA). Release of sirolimus from these coatings showed an important burst effect of drug whatever the nature of PHAs due to their very low glass transition temperatures. However, bilayer systems offered many options for controlling sirolimus release over months.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
